Jung-Mao Hsu
- Molecular Biology top 2%
- Oncology top 0.5%
- Immunology top 1%
- Cancer Research top 2%
- Pulmonary and Respiratory Medicine top 5%
- Co-authors
- Mien‐Chie HungHirohito YamaguchiWeiya XiaJennifer L. HsuChia‐Wei LiGabriel N. HortobágyiChun‐Te ChenChao‐Kai Chou
- Topics
- Cancer Immunotherapy and Biomarkers (9 papers)Immunotherapy and Immune Responses (6 papers)Peptidase Inhibition and Analysis (4 papers)
- Cited by
- OncologyImmunologyCancer Research
- Partner nations
- TaiwanUnited StatesChina
In The Last Decade
Jung-Mao Hsu
56 papers receiving 6.0k citations
Hit Papers
Peers
Comparison fields: 5 of 113
- Molecular Biology 3.5k
- Oncology 3.0k
- Immunology 1.6k
- Cancer Research 1.0k
- Pulmonary and Respiratory Medicine 730
Countries citing papers authored by Jung-Mao Hsu
This map shows the geographic impact of Jung-Mao Hsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jung-Mao Hsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jung-Mao Hsu more than expected).
Fields of papers citing papers by Jung-Mao Hsu
This network shows the impact of papers produced by Jung-Mao Hsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jung-Mao Hsu. The network helps show where Jung-Mao Hsu may publish in the future.
Co-authorship network of co-authors of Jung-Mao Hsu
This figure shows the co-authorship network connecting the top 25 collaborators of Jung-Mao Hsu. A scholar is included among the top collaborators of Jung-Mao Hsu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jung-Mao Hsu. Jung-Mao Hsu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 8 | |
| 3 | 36 | |
| 4 | TYRO3 induces anti–PD-1/PD-L1 therapy resistance by limiting innate immunity and tumoral ferroptosisbreakdown → | 255 |
| 5 | Molecular mechanisms and functions of pyroptosis in inflammation and antitumor immunitybreakdown → | 216 |
| 6 | 112 | |
| 7 | 133 | |
| 8 | 154 | |
| 9 | PARP Inhibitor Upregulates PD-L1 Expression and Enhances Cancer-Associated Immunosuppressionbreakdown → | 768 |
| 10 | 7 | |
| 11 | 26 | |
| 12 | 21 | |
| 13 | 39 | |
| 14 | 195 | |
| 15 | 328 | |
| 16 | 49 | |
| 17 | 163 | |
| 18 | 81 | |
| 19 | 38 | |
| 20 | 16 |
About Jung-Mao Hsu
Jung-Mao Hsu is a scholar working on Oncology, Immunology and Molecular Biology, having authored 56 papers that have together received 6.1k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (9 papers), Immunotherapy and Immune Responses (6 papers) and Peptidase Inhibition and Analysis (4 papers). The work is most often cited by research in Oncology (3.0k citations), Immunology (1.6k citations) and Cancer Research (1.0k citations). Jung-Mao Hsu has collaborated with scholars based in Taiwan, United States and China. Frequent co-authors include Mien‐Chie Hung, Hirohito Yamaguchi, Weiya Xia, Jennifer L. Hsu, Chia‐Wei Li, Gabriel N. Hortobágyi, Chun‐Te Chen, Chao‐Kai Chou, Wenhao Yang and Yongkun Wei. Their work appears in journals such as Science, Journal of Biological Chemistry and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.